However, recent research21 suggests that ALK fusion oncogenes may enhance tumor cell viability by up-regulating SERPINB4 (serpin family B member 4) expression and inhibiting the immunoactivity of natural killer cells, enabling tumor cells to evade immune clearance. Here, SERPINB4 is linked to neoplasm.